The JAID/JSC guidelines to Clinical Management of Infectious Disease 2017 concerning male urethritis and related disorders.

Authors :: Hamasuna R
Yasuda M
Takahashi S
Uehara S
Kawai Y
Miyairi I
Arakawa S
Kiyota H
Source :: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Apr; Vol. 27 (4), pp. 546-554. Date of Electronic Publication: 2021 Jan 28.
Publication Year :: 2021
Abstract: Competing Interests: Declaration of Competing Interest Soichi Arakawa received a lecture fee from Taisho Toyama Pharmaceutical Co., Ltd. Ryoichi Hamasuna received a lecture fee from Daiichi Sankyo Co., Ltd., research funds from EIDIA Co., Ltd. Hiroshi Kiyota received donations from Daiichi Sankyo Co., Ltd., Toyama Pharmaceutical Co., Ltd., Astellas Pharm Inc., Sanofi K.K., Taisho Toyama Pharmaceutical Co. Ltd. and Taiho Pharmaceutical Co. Ltd. Satoshi Takahashi received donations from Shino-Test Co. Ltd and Daiichi Sankyo Co., Ltd.,

Subjects :: Humans
Male
Communicable Diseases
Gonorrhea
Urethritis diagnosis
Urethritis drug therapy

Language :: English
ISSN :: 1437-7780
Volume :: 27
Issue :: 4
Database :: MEDLINE
Journal :: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Publication Type :: Academic Journal
Accession number :: 33516669
Full Text :: https://doi.org/10.1016/j.jiac.2019.12.001

Full Text Access

Tools